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Background/introduction
Magnetic Resonance guided Focused Ultrasound
(MRgFUS) has been recently proven and was approved by
the FDA as an effective method for pain palliation in
patients with painful bone metastases from the US, Europe
and Russia. This report describes the first clinical experi-
ence in Taiwan.
Methods
Between May and June 2014, 8 patients suffering from
painful bone metastases were identified and recruited by
the radiation oncology departments of Taipei Medical
University Hospital, Wan Fang Hospital and Shuang Ho
Hospital in Taipei, Taiwan. All patients chose to undergo
MRgFUS treatment as their first choice of treatment for
their painful bone lesions. Treatment was conducted using
the ExAblate system (InSightec Ltd.), which integrates a
focused ultrasound phased array therapeutic compartment
with a magnetic resonance imaging (MRI) scanner (GE
1.5T MRI). Therapeutic ultrasound waves were targeted to
the painful lesions while monitoring the accumulated heat
using real-time MR images. Efficacy of MRgFUS treatment
was evaluated using the numerical rating scale (NRS),
before treatment, and at 1 and 3 days; 1 and 2 weeks and
at 1 month after treatment. (3 months follow-up results
will be collected and reported when available).
Results and conclusions
The median age of the 8 treated patients (5 male and 3
female) was 58 years old (range, 40 – 76). Each patient
underwent treatment of a single lesion.
Majority of treatments were aimed at lesions located in
the pelvis (5 sacro-iliac joints and one ilium), one at the
femur and one at the sterno-clavicular joint. Three of the
targeted lesions were osteoblastic, two osteolytic and three
were mixed. None of the patients experienced any proce-
dure related adverse events and the treatment was toler-
ated well by all. At day 1 post-treatment, 100% of patients
reported a significant reduction of pain (median 3.5 points
reduction in the NRS, P<0.001) from median baseline
NRS of 6 (4-8). By the first month after treatment the
median NRS decreased to 3 (range, 1-5, P=0.001). 25% of
patients experienced complete response (pain score
decreased to 0). The median length of the procedure
(patient walk-in to walk-out) was 01:45 hours (01:05 to
02:20 hours), of which the median treatment time was
52 minutes (25-80). The results of these 8 primary treat-
ments are similar to those of Hurwitz et al (2014) which
were mainly obtained from radiation failures or patients
who could not obtain radiation.
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